Pascot, A., Lemieux, I., Prud’homme, D., Tremblay, A., Nadeau, A., Couillard, C., Bergeron, J., Lamarche, B. and Despres, J.P. (2001) Reduced HDL Particle Size as an Additional Feature of the Atherogenic Dyslipidemia of Abdominal Obesity. Journal of Lipid Research, 42, 2007-2014.

has been cited by the following article:

• TITLE: Atherogenic Indices and HDL Particle Size as Laboratory Parameters to Evaluate Cardiovascular Risk in the Presence of Dyslipidemia

  AUTHORS: Ana Paula C. Santos, Marcos S. Vieira, Débora F. Deus, Rogério Jorge B. de Oliveira, Aleksandra T. Morikawa, Roque Aras, Ajax M. Atta, Fabio D. Couto, Raul C. Maranhão, Ricardo D. Couto

  KEYWORDS: Dyslipidemia, Atherogenic Indices, Cardiovascular Risk

  JOURNAL NAME: Journal of Biophysical Chemistry, Vol.5 No.2, April 23, 2014

  ABSTRACT: Dyslipidemia may influence enzymes and transfer proteins needed to the lipoprotein particle remodeling. Calculated indices and evaluation of lipoprotein particle size have widely been used to predict cardiovascular risk. The aim of this study was to evaluate HDL particle size and LDL particle size estimate based on TG/HDL-C as well as apoB/apoA-I ratio as possible marker and atherogenic indices, respectively, of cardiovascular disease risk in the presence of dyslipidemia. We evaluated 100 individuals of both gender, without treatment with lipid-lowering drugs, 27 normolipidemic and 73 dyslipidemic, such as isolated hypercholesterolemia (n = 16), isolated hypertriglyceridemia (n = 17), low HDL-C (n = 26) and mixed dyslipidemia (n = 14). The HDL particle size did not differ between groups. The TG/HDL-C ratio was higher in groups with isolated hypertriglyceridemia (4.2 ± 1.5), low HDL-C (5.2 ± 3.1) and mixed dyslipidemia (5.3 ± 1.6). The apoB/apoA-I ratio was increased in all groups of dyslipidemia (apoB/apoA-I > 0.5) when compared to normolipidemic (apoB/apoA-I = 0.5, p